Cellective Therapeutics

Gaithersburg, MD

Ticker: Nasdaq: MEDI

http://www.medimmune.com

Cellective was a biopharmaceutical company focused on developing industry-leading therapeutic antibodies for the treatment of oncology and immune-related diseases. The company was acquired by MedImmune in 2005.

Read Success Story